Stock Comparison

ARGX vs MDGL

argenx NV ADR and Madrigal Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

MDGL

Madrigal Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$53.23B

$11.60B

P/E (TTM)

32.7

—

Forward P/E

30.4

656.4

Price/Sales

10.0

9.0

Price/Book

6.4

22.1

EV/EBITDA

27.6

-8.2

Dividend Yield

—

Profitability

Net Margin

30.44%

-27.32%

Operating Margin

27.34%

-27.68%

Return on Equity

23.60%

-53.30%

Return on Assets

11.60%

-17.80%

Growth (YoY)

Revenue Growth

59.30%

71.20%

Earnings Growth

95.20%

0.00%

Price & Risk

Beta

-0.0

-1.0

52-Week High

$939.68

$602.83

52-Week Low

$652.43

$369.84

Analyst Target

$1,085.78

$678.06

Compare ARGX and MDGL your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.